Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Deals & Financings

Summit Expands Rights for Akeso’s PD-1/VEGF Bispecific in $70 Million Agreement
Burning Rock to Develop Diagnostic Assays for Bayer’s Precision Drugs
Bio-Thera Out-licenses EU Rights for Arthritis Biosimilar in $157 Million Deal
Japan’s Asahi Kasei in $1.1 Billion Deal to Acquire Calliditas
HuidaGene Partners Use of CRISPR nuclease (hfCas12Max) with Synthego
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital